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Abstract 
A simple, fast, accurate and precise RP-HPLC method were developed and validated for the estimation of 
Azithromycin & Benzoyl peroxide per ICH guidelines. Potassium dihydrogen phosphate and Acetonitrile (50:50) 
are commonly used as solvents. The method was developed in Eclipse C18 column (Waters XTerra®, 4.6Χ250 mm, 
particle 5μ) with Potassium dihydrogen phosphate and Acetonitrile are commonly used solvents in RP -HPLC 
having low UV cut- off of 200-400 nm respectively. In RP-HPLC method was found to be linear in the range of 
Azithromycin/Benzoyl peroxide is 1-5µg/ml with a correlation coefficient value of 0.99. The accuracy studies of 
RP-HPLC method was performed at three different levels, i.e., 80%, 100%. The limit of detection (LOD) and Limit 
of Quantification (LOQ) for Azithromycin 0.009µg/ml & 0.028µg/ml and for Benzoyl peroxide 0.015µg/ml & 
0.046µg/ml is to be were found. The Percentage RSD should not be more than 2 which indicate the accuracy and 
precision of the method. Hence the method was robust.Thus this shows that the method is capable to give a good 
detector response, the recovery calculated was within the range of 98% to 101% of the specification limits. Hence 
the method was a rapid tool for routine analysis of Azithromycin/Benzoyl peroxide in the bulk and in the 
pharmaceutical dosage form. 
Keywords: Method validation, RP-HPLC, Azithromycin & Benzoyl peroxide. 
Introduction 
 
Azithromycin is an antibiotic useful for the treatment 
of a number of bacterial infections. This includes 
middle ear infections, strep throat, pneumonia, 
traveler's diarrhea, and certain other intestinal 
infections. It may also be used for a number of  
sexually transmitted infections including Chlamydia 
and gonorrhea infections. Along with other 
medications, it may also be used for malaria. It can be 
taken by mouth or intravenously with doses once per 
day. Azithromycin prevents bacteria from growing by 
interfering with their protein synthesis. It binds to the 
50S subunit of the bacterial ribosome, thus inhibiting 
translation of mRNA but Nucleic acid synthesis is not 
affected.  
____________________ 
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Azithromycin was first discovered in 1980. It is on the 
World Health Organization's List of Essential 
Medicines, the most effective and safe medicines 
needed in a health system.  
Benzoyl peroxide is a medication and industrial 
chemical  and a medication which used to treat mild to 
moderate acne. Other uses include  hair bleaching, 
teeth whitening, and textile bleaching.  Benzoyl 
peroxide is used as an acne treatment. Benzoyl 
peroxide is lipophilic drug. When applied to the skin it 
is capable of penetrating into the pilosebaceous follicle. 
After penetration in the skin, benzoyl peroxide releases 
free radical oxygen and benzoic acid. The free radicals 
oxidize bacterial proteins thus, higher concentrations of 
benzoyl peroxide applied to the skin result in larger 
amounts of drug in the skin. The benzoic acid is 
cleared rapidly by the kidneys and excreted unchanged 
in the urine. [22] It improves both inflammatory and 
non-inflammatory lesions of acne. Benzoyl peroxide 
was first made in 1905 and came into medical use in 
the 1930s. It is on the World Health Organization's List 
of Essential Medicines. Keeping this point into 
consideration, an attempt was made to develop a 
simple, accurate and validated stability indicating RP-
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HPLC method for the estimation of Azithromycin and 
Benzoyl peroxide in pure and tablet form. The 
proposed Method was validated as per ICH guidelines. 
 
Experimental  
 Chemicals and Reagents: Analytically pure sample 
of Azithromycin and Benzoyl peroxide with purity 
greater than 98% manufactured by Heliox Pharma and 
SGPTC Pvt. Ltd.was used. Acetonitrile (HPLC grade) 
was obtained from Fischer, Potassium dihydrogen 
phosphate ((HPLC grade, Thomas Baker, Mumbai), 
Methanol (HPLC & Spectroscopy grade was used. 
Instruments and apparatus 
RP-HPLC was performed using RP-HPLC instrument 
equipped with an UV-Visible detector and a 
photodiode array detector (LC-2010, Shimadzu, 
Japan), an auto-sampler; column used was Welchrome 
C18 (4.6 × 250 mm i.d., 5 μm particle size) and an LC-
solution software. 
Chromatographic conditions 
Preliminary experiments were conducted to identify the 
critical attribute factors (CQAF) and to set their 
minimum and maximum levels using Taguchi 
screening method for design of experiments. Initially 
following parameters were investigated: selection of a 
column (C8 and C18), mobile phase (ratio of 30mM 
Potassium dihydrogen phosphate buffer: Acetonitrile), 
column temperature, detector wavelength, pH of 
mobile phase, mode of flow (isocratic/gradient) as well 
as ideal flow rate and the injection volume and 
evaluated for the risk management method process 
parameters viz. Number of theoretical Plates (TP), 
Assay, and tailing factor (TF). 
Standard Stock Solution Preparation (100 μg/ml) 
An accurately weighed quantity of about 10 mg of 
Azithromycin and 10 mg of Benzoyl peroxide 1ml 
appended, about 1 ml of diluents was added and 
sonicate to dissolve. From this took Suitable amount of 
sample further dilute to form 100 μg/ml.  
Preparation of mobile phase of Azithromycin and 
Benzoyl peroxide 
A filtered and degassed mixture of 300Mm Potassium 
Dihydrogen Phosphate Buffer and Acetonitrile (50:50) 
was prepared and used as mobile phase. Selection of 
flow rate of Azithromycin/Benzoyl peroxide. As 
increase in the flow rate results in decrease in the 
retention time. Hence sufficient flow rate of 0.8 
ml/min. was chosen to avoid overlap between the peaks 
and the loss of its acceptable resolution values. 
Preparation of sample solution of Azithromycin and 
Benzoyl peroxide 
20 Tablets of contents were weighed and the average 
weight was determined. They were crushed in to fine 
powder with glass mortar. The tablet powder 
equivalent to 100 mg of Azithromycin and Benzoyl 
peroxide was transferred to a 100 ml volumetric flask 
and dissolved in mobile phase and the content was 
made up to mark with mobile phase. Then the sample 
solution kept in Sonicator for 15 min and the solution 
was filtered through the Whatman filter paper no. 41. 
(Whatman International Ltd., England). The filtrate 
contains 10μg/ml of of Azithromycin and Benzoyl 
peroxide to give the respective concentrations as par 
with standard solution. 
System Suitability studies of Azithromycin/Benzoyl 
peroxide 
According to the USP, system suitability tests are an 
integral part of chromatographic methods. These tests 
are used to verify that the resolution and 
reproducibility of the system are adequate for the 
analysis to be performed. System suitability tests are 
based on the concept that the equipment, electronics, 
analytical operations, and samples constitute an 
integral system that can be evaluated as a whole. The 
purpose of the system suitability test is to ensure that 
the complete testing system (including instrument, 
reagents, columns, analysts) is suitable for the intended 
application. 
 
Assay Procedure for Azithromycin/Benzoyl 
peroxide 
From the standard stock solution, each level solution 
was injected into the chromatographic system and the 
peak area was measured. A graph of peak area versus 
concentration (on X-axis concentration and on Y-axis 
Peak area) was plotted and the correlation coefficient 
was calculated. The linearity of the method was 
demonstrated over the concentration range of 
Azithromycin/Benzoyl peroxide 1 μg/ml to 5 μg/ml. 
The solutions were injected in to HPLC system as per 
test procedure. HPLC Chromatogram was recorded of 
each concentration and the calibration curve was 
plotted (area vs. concentration). The regression 
equation and correlation coefficient were obtained. 
Preparation of sample stock solution of 
Azithromycin/Benzoyl peroxide 
About 10mg of Azithromycin/Benzoyl peroxide 
samples was weighed in to volumetric flask, it was 
dissolved with Potassium Dihydrogen Phosphate 
Buffer and Acetonitrile (50:50) and the volume was 
made up to the mark with same diluents (10μg/ml of 
Azithromycin/Benzoyl peroxide). 
Validation of Spectrophotometric (RP-HPLC) 
method  
The proposed RP-HPLC method was validated as per 
ICH guidelines. 
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Linearity and Range studies of 
Azithromycin/Benzoyl peroxide 
The linearity of analytical method is its ability to elicit 
test results that are directly proportional to the 
concentration of analyte in sample within a given 
range. The range of analytical method is between the 
upper and lower levels of analyte that have been 
demonstrated to be determined within a suitable level 
of precision, accuracy and linearity. Selected linearity 
range for Azithromycin was 1-5 μg/ml and for Benzoyl 
peroxide it was 1-5 μg/ml. 
Accuracy studies of Azithromycin/Benzoyl peroxide 
Accuracy of the method was determined in terms of % 
recovery of standard. Recovery studies were carried 
out by addition of standard drug solution at the level of 
80%, 100% and 120% to the pre-analyzed sample. 
Results of the recovery study were found to be within 
the acceptance criteria 100±10 %, indicating a good 
degree of sensitivity of the method towards detection 
of analyte (s) in sample. In this method the known 
concentration of standard drug was added to the assay 
sample.  
Precision studies of Azithromycin/Benzoyl peroxide 
The intra-day and inter-day variation for determination 
of Azithromycin and Benzoyl peroxide hydrochloride 
were carried out Six times in the same day and six 
consecutive days using concentration 5 μg/ml of 
Azithromycin and Benzoyl peroxide % RSD was 
calculated. The method was found to be precise due to 
low values of the %RSD. 
LOD and LOQ studies of Azithromycin/Benzoyl 
peroxide 
The LOD and LOQ of developed method were studied 
as per ICH guidelines. Several approaches for 
determining the LOD & LOQ are possible, depending 
on the procedure i.e, a non-instrumental or 
instrumental. Among them here employed method was, 
LOD=3.3σ/Sand                                                             
LOQ= 10σ/S 
Where, σ = the standard deviation of response                    
S = the slope of calibration curve. 
Robustness studies of Azithromycin/Benzoyl 
peroxide 
The robustness was studied by analyzing the same 
samples of Azithromycin and Benzoyl peroxide 
concentration 5 μg/ml by deliberate variation in the 
method parameters. The change in the responses of 
Azithromycin and Benzoyl peroxide were noted in 
terms of %RSD. Robustness of the method was studied 
by change in wavelength or change in flow rate, 
change in Ph of mobile phase. . 
 
Results and Discussion 
Selection of mobile phase and flow rate of 
Azithromycin/Benzoyl peroxide  
Initially various mobile phase compositions were tried, 
to separate title ingredients. Mobile phase composition 
and flow rate selection was based on peak parameters 
(height, tailing, theoretical plates, capacity or 
symmetry factor) and run time. The optimized mobile 
phase ratio (v/v) consisted of Acetonitrile and buffer 
(50:50), pH 6.5 with 1.1 ml/min of flow rate. Flow rate 
was found to be quite robust. The optimum wavelength 
for detection was 235nm for Benzoyl peroxide and 
215nm for Azithromycin at which better detector 
response was obtained. The retention time was found to 
be 22.0min for Azithromycin and 2.5min for Benzoyl 
peroxide and the total runtime for this method along 
with the elution of and indicates that the developed 
method is quite fast and economical. 
Calibration curve for Azithromycin/Benzoyl 
peroxide 
Appropriate aliquots from standard 
Azithromycin/Benzoyl peroxide stock solutions were 
transferred into different volumetric flasks of 10ml 
capacity and the volume is adjusted to the mark to 
obtain concentrations of 1 μg/ml to 5 μg/ml of 
Azithromycin/Benzoyl peroxide. 
Method Validation 
Linearity  
The correlation coefficient (R) obtained was calculated 
and it was found to be greater than 0.99 for Benzoyl 
peroxide and Azithromycin given in below table, 
which is well within the acceptance criteria. The results 
are shown in Table 1, 2, 3. The concentration was 
found to be proportional to the area and the response of 
the detector was determined to be linear over the range 
of 1-5 µg/ml for both Benzoyl peroxide and 
Azithromycin shown in Figure 1 & 2. 
 
Table 1: Regression coefficient value for both drugs 
 
S.No. Name of drug Linearity range Regression coefficient value 
1 Benzoyl peroxide 1-5µg/ml 0.998 
2 Azithromycin 1-5µg/ml 0.997 
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Table 2: Linearity of Benzoyl peroxide 
S.No. Concentration (µg/ml) Retention Time     Area 
1 1 2.5 86427±1.24 
2 2 2.5 154040±1.34 
3 3 2.5 225070±0.93 
4 4 2.54 307274±0.54 
5 5 2.5 382581±1.19 
 
 
Figure 1: Linearity of Benzoyl peroxide 
 
Table 3: Linearity of Azithromycin 
S.No. Concentration (µg/ml) Retention Time (min.) Area 
1 1 22.033 125359±0.68 
2 2 22.136 206308±1.12 
3 3 22.221 308004±1.03 
4 4 22.156 413253±0.93 
5 5 22.156 512581±1.30 
 
 
Figure 2: Linearity of Azithromycin 
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Accuracy 
The results indicate that the recoveries are well within 
the acceptance range of 80 – 120%, therefore, method 
is accurate and it can be used for the simultaneous 
estimation of Benzoyl peroxide and Azithromycin. 
Accuracy of both drugs was given in below table 4, 5, 
6, 7, 8, 9. 
 
Table 4: Accuracy of 80% sample of Benzoyl peroxide 
 
Concentration ((µg/ml) Retention Time Area 
8µg/ml 2.551 233217 
8µg/ml 2.551 233217 
8µg/ml 2.549 233317 
 Mean 233250.3333 
S.D. 57.73502687 
%RSD 0.024752388 
 
Table 5: Accuracy of 80% sample of Azithromycin 
 
Concentration (µg/ml) Retention Time Area 
8µg/ml 22.121 284135 
8µg/ml 22.021 286741 
8µg/ml 22.034 289434 
 Mean 286770 
S.D. 2649.619029 
%RSD 0.923952655 
         
Table 6: Accuracy of 100 % sample of Benzoyl peroxide 
 
Concentration Retention Time Area 
10µg/ml 2.549 303657 
10µg/ml 2.537 307274 
10µg/ml 2.542 307944 
 Mean 306291.6667 
S.D. 2306.149677 
%RSD 0.752926027 
 
Table 7: Accuracy of 100 % sample of Azithromycin 
 
Concentration Retention Time Area 
10µg/ml 22.156 410191 
10µg/ml 22.101 413253 
10µg/ml 22.056 411233 
 Mean 411559 
S.D. 1556.813412 
%RSD 0.378272231 
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Table 8: Accuracy of 120 % sample of Benzoyl peroxide 
 
Concentration Retention Time Area 
12µg/ml 2.461 396553 
12µg/ml 2.462 394973 
12µg/ml 2.460 398143 
 Mean 396556.3333 
S.D. 1585.002629 
%RSD 0.399691669 
 
Table 9: Accuracy of 120 % sample of Benzoyl peroxide 
 
Concentration Retention Time Area 
12µg/ml 22.230 447899 
12µg/ml 22.241 447327 
12µg/ml 22.233 440002 
 Mean 445076 
S.D. 4403.510304 
%RSD 0.989383904 
 
Method Precision 
It is a measure of degree of repeatability of an 
analytical method under normal operation and it is 
normally expressed as % of relative standard deviation 
(% RSD). The standard solution was injected for five 
times and measured the area for all five injections in 
HPLC. The %RSD for the area of six replicate 
injections was found to be within the specified limits. 
Similarly % RSD for Interday Precision and Intraday 
Precision was given below that was found to be within 
the specified limits. The percentage RSD values for 
Area and Retention Time in precision study were 
calculated. Chromatogram of Repeatability, Interday 
precision and Interday precision was given below.  
Table 10: Repeatability of Benzoyl peroxide and Azithromycin 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 398542 22.230 472613 
2 5 2.468 398561 22.198 472408 
3 5 2.452 398554 22.261 472554 
4 5 2.391 398497 22.268 472621 
5 5 2.398 398562 22.201 472406 
6 5 2.460 398599 22.231 472513 
Mean 398552.5 Mean 472519.166 
Standard Deviation 33.21897048 Standard Deviation 95.4890917 
%RSD 0.008334905 %RSD 0.02020851 
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Figure 3: Chromatogram of repeatability of Benzoyl peroxide and Azithromycin 
 
Table 11: Interday Precision of Benzoyl peroxide and Azithromycin 
 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 393118 22.230 445826 
2 5 2.468 388054 22.198 441695 
3 5 2.452 388259 22.261 441715 
4 5 2.391 385556 22.268 424972 
5 5 2.398 391289 22.201 430122 
6 5 2.460 391281 22.231 442054 
Mean 389592.8333 Mean 437730.6667 
Standard Deviation 2778.374735 Standard Deviation 8203.558586 
%RSD 0.713148317 %RSD 1.874111003 
 
 
Figure 4: Interday Precision of Benzoyl peroxide and Azithromycin 
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Table 12: Intraday Precision of Benzoyl peroxide and Azithromycin 
 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 390594 22.23 450254 
2 5 2.461 398561 22.230 472408 
3 5 2.460 390277 22.232 446708 
4 5 2.462 387714 22.241 451804 
5 5 2.460 398143 22.232 458372 
6 5 2.462 390216 22.241 456409 
Mean 392584.1667 Mean 455992.5 
Standard Deviation 4587.672238 Standard Deviation 9077.224108 
%RSD 1.168583103 %RSD 1.990652063 
 
 
Figure 5: Intraday Precision of Benzoyl peroxide and Azithromycin 
LOD and LOQ 
The Limit of detection and limit of quantification of the 
method were calculated basing on standard deviation of 
the response and the slope (s) of the calibration curve 
at approximate levels of the limit of detection and limit 
of quantification. The data were represented in Table 
13. The results obtained were within the limit.  
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Table 13: LOD and LOQ of Benzoyl peroxide and Azithromycin 
 
S.No. Parameter Benzoyl peroxide Azithromycin  
1 LOD 0.015µg/ml 0.009µg/ml 
2 LOQ 0.046µg/ml 0.028µg/ml 
 
Robustness 
The Robustness of the method was found out by testing 
the effect of small deliberate changes in the 
chromatographic conditions in the chromatographic 
conditions and the corresponding peak areas. The 
factors selected for this purpose were flow rate, Change 
in wavelength and pH variation in the mobile phase. 
The method was found to be robust enough that the 
peak area was not apparently affected by small 
variation in the chromatographic conditions. The 
system suitability parameters were within the limits 
and shown in Table 14-19 and chromatograms were 
represented in Figure 6-13. 
The Percentage RSD should not be more than 2. The 
%RSD obtained for change of flow rate, Change in 
wavelength and pH variation in the mobile phase was 
found to be below 2, which was within the acceptance 
criteria. Hence the method was robust. 
(A) Change in flow Rate 
Table 14: Robustness of Benzoyl peroxide and Azithromycin at 0.9ml/min 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.511 393329 22.403 441848 
2 5 2.460 398143 22.232 447800 
3 5 2.560 398143 22.232 447800 
Mean 396538.3333 Mean 445816 
Standard Deviation 2779.364196 Standard 
Deviation 
3436.388802 
%RSD 0.700906813 %RSD 0.770808765 
 
Figure 6: Table: Robustness of Benzoyl peroxide and Azithromycin at 0.9 ml/min 
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Table 15:  Robustness of Benzoyl peroxide and Azithromycin at 1ml/min 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 398542 22.230 472613 
2 5 2.468 398561 22.198 472408 
3 5 2.452 398554 22.261 478554 
Mean 398552.3333 Mean 474525 
Standard Deviation 9.609023537 Standard Deviation 3490.721559 
%RSD 0.002410982 %RSD 0.735624374 
 
 
Figure 7:  Robustness of Benzoyl peroxide and Azithromycin at 1ml/min. 
 
Table 16: Robustness of Benzoyl peroxide and Azithromycin at 1.1ml/min. 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 398542 22.230 472613 
2 5 2.468 398561 22.198 472408 
3 5 2.452 398554 22.261 478554 
Mean 398552.3333 Mean 474525 
Standard Deviation 9.609023537 Standard Deviation 3490.721559 
%RSD 0.002410982 %RSD 0.735624374 
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Figure 8: Robustness of Benzoyl peroxide and Azithromycin at 1.1ml/min 
 
Change in wavelength 
Table 17: Robustness of Benzoyl peroxide and Azithromycin at 230nm 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 395237 22.230 428676 
2 5 2.461 391998 22.230 432408 
3 5 2.460 395239 22.232 432217 
Mean 394158 Mean 431100.3333 
Standard Deviation 1870.615139 Standard Deviation 2101.705101 
%RSD 0.4745851 %RSD 0.487521103 
 
 
Figure 9: Robustness of Benzoyl peroxide and Azithromycin at 230 nm 
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Table 18: Robustness of Benzoyl peroxide and Azithromycin at 240 nm 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide      Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.461 398561 22.230 472408 
2 5 2.460 396557 22.232 488372 
3 5 2.460 389518 22.232 484185 
Mean 394878.6667 Mean 481655 
Standard Deviation 4749.375152 Standard Deviation 8277.25794 
%RSD 1.202742906 %RSD 1.718503481 
 
Table 19: Robustness of Benzoyl peroxide and Azithromycin at 235 nm 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide   Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.391 398497 22.268 472621 
2 5 2.398 398562 22.201 472406 
3 5 2.460 398599 22.231 472513 
Mean 398552.6667 Mean 472513.3333 
Standard Deviation 51.63655046 Standard Deviation 107.5003875 
%RSD 0.012956017 %RSD 0.022750763 
 
Figure 10: Robustness of Benzoyl peroxide and Azithromycin at 235 nm 
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Change in PH of mobile phase 
Table 20: Robustness of Benzoyl peroxide and Azithromycin at 6.4 pH 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.516 393329 22.413 441848 
2 5 2.460 398143 22.232 447800 
3 5 2.560 398143 22.232 447800 
Mean 396538.3333 Mean 445816 
Standard Deviation 2779.364196 Standard Deviation 3436.388802 
%RSD 0.700906813 %RSD 0.770808765 
 
 
 Figure 11: Robustness of Benzoyl peroxide and Azithromycin at 6.4 pH 
 
 
Table 21: Robustness of Benzoyl peroxide and Azithromycin at 6.5 pH 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.391 398497 22.268 472621 
2 5 2.398 398562 22.201 472406 
3 5 2.460 398599 22.239 472513 
Mean 398552.6667 Mean 472513.3333 
Standard Deviation 51.63655046 Standard Deviation 107.5003875 
%RSD 0.012956017 %RSD 0.022750763 
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Figure 12: Robustness of Benzoyl peroxide and Azithromycin at 6.5 pH 
 
Table 22: Robustness of Benzoyl peroxide and Azithromycin at 6.6 pH 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.459 398738 22.231 443032 
2 5 2.461 398561 22.230 430015 
3 5 2.463 398561 22.235 442408 
Mean 398620 Mean 438485 
Standard Deviation 102.1909976 Standard Deviation 7341.867542 
%RSD 0.025636194 %RSD 1.674371425 
 
 
Figure 13: Robustness of Benzoyl peroxide and Azithromycin at 6.6 pH 
 
Ruggedness 
The Ruggedness of the method was found out by 
testing the effect of small deliberate changes in the 
analyst. The method was found to be robust enough 
that the peak area was not apparently affected by small 
variation in the chromatographic conditions. The 
system suitability parameters were within the limits 
and shown in Table No. 23, 24 and chromatograms 
were represented in Figure 14, 15 
The Percentage RSD should not be more than 2. The 
%RSD obtained for change of analyst was found to be 
below 2, which was within the acceptance criteria. 
Hence the method was rugged. 
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Table 23: Ruggedness of Benzoyl peroxide and Azithromycin by analyst one 
 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.569 398545 23.230 482613 
2 5 2.568 398561 23.198 482438 
3 5 2.602 398554 23.248 488565 
Mean 398553.3333 Mean 484538.6667 
Standard Deviation 8.020806277 Standard Deviation 3488.004635 
%RSD 0.00201248 %RSD 0.719860947 
 
 
Figure 14: Ruggedness of Benzoyl peroxide and Azithromycin by analyst one 
 
Table 24: Ruggedness of Benzoyl peroxide and Azithromycin by analyst two 
 
S.No. Concentration 
(µg/ml) 
Benzoyl Peroxide Azithromycin 
Retention time 
(min.) 
Area Retention time 
(min.) 
Area 
1 5 2.578 398546 23.331 472513 
2 5 2.578 388561 22.268 473408 
3 5 2.496 398564 23.268 487554 
Mean 395223.6667 Mean 477825 
Standard Deviation 5770.045609 Standard Deviation 8437.436637 
%RSD 1.459944355 %RSD 1.765800583 
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Figure 15: Ruggedness of Benzoyl peroxide and Azithromycin by analyst two 
 
Figure 16: Molecular Structure of Azithromycin 
 
Figure 17: Molecular Structure of Benzoyl peroxide 
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Melting point: Melting point of Azithromycin was found to be 114-116°C and for benzoyl peroxide 104-106°C 
FT-IR: FT-IR spectra of both drugs and mixture of both drugs were given below. 
 
Figure 18: IR spectra of Azithromycin 
 
Figure 19: IR spectra of Benzoyl Peroxide 
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Figure 20: IR spectra of mixture of Azithromycin and Benzoyl Peroxide 
 
From the figure no. 18, 19, 20 it was found that there was no interaction either physical or chemical in between both 
drugs. 
 
Conclusion 
High performance liquid chromatography at present 
one of the most sophisticated tool of the analysis. The 
estimation of Imatinib Azithromycin and Benzoyl 
Peroxide was done by RP-HPLC Method. The mobile 
phase was optimized with consists of Potassium 
Dihydrogen Phosphate Buffer and Acetonitrile (50:50). 
A C18 column (4.6Χ250 mm, particle 5μ, Make: 
Waters XTerra®) was used as stationary phase. The 
solutions were chromatographed at a constant flow rate 
of 1.1 ml/min. The linearity range of Azithromycin and 
Benzoyl Peroxide were found to be from 1-5 µg/ml.  In 
this method, correlation coefficient was found to be 
0.998 for Benzoyl peroxide and 0.997 for 
Azithromycin. The maximum absorbance is found to 
be at 235nm for Benzoyl peroxide and 215nm for 
Azithromycin. The value of % RSD was found to be 
within the specified limits which indicating accuracy 
and precision of the method. LOD and LOQ were 
found to be within limit. The results obtained on the 
validation parameters met ICH and USP requirements. 
The method was found to be accurate, precise, 
repeatable and reproducible with different instruments 
and analysts. So, simple, sensitive, accurate, precise 
RP- HPLC methods were developed and validated for 
the simultaneous estimation of Benzoyl peroxide and 
Azithromycin. 
The method also finds use in clinical, biological and 
pharmacokinetic studies for the drug Azithromycin and 
Benzoyl peroxide. The method was validated as per 
ICH guidelines, and validation acceptance criteria were 
met in all cases. Hence, this method was specific, 
stability-indicating and can be successfully used for the 
estimation of drug in bulk and pharmaceutical dosage 
forms. 
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